CD79A and diffuse large B-cell lymphoma: Of these markers, HIV-infected DLBCL patients had a high expression rate of EBER (41.7% vs. 6.7%, p = 0.002) but low expression rates of CD20 (90.2% vs. 98.7%, p = 0.029) and CD79a (23.1% vs. 53.7%, p < 0.001).